Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1) - PubMed (original) (raw)
Randomized Controlled Trial
. 2009 Oct;32(10):1796-801.
doi: 10.2337/dc09-0676. Epub 2009 Jul 8.
Affiliations
- PMID: 19587369
- PMCID: PMC2752907
- DOI: 10.2337/dc09-0676
Randomized Controlled Trial
Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1)
Chamukuttan Snehalatha et al. Diabetes Care. 2009 Oct.
Abstract
Objective: The Indian Diabetes Prevention Programme-1 (IDPP-1) showed that lifestyle modification (LSM) and metformin were effective for primary prevention of diabetes in subjects with impaired glucose tolerance (IGT). Among subjects followed up for 3 years (n = 502), risk reductions versus those for the control group were 28.5, 26.4, and 28.2% in LSM, metformin (MET), and LSM plus MET groups, respectively. In this analysis, the roles of changes in secretion and action of insulin in improving the outcome were studied.
Research design and methods: For this analysis, 437 subjects (93 subjects with normoglycemia [NGT], 150 subjects with IGT, and 194 subjects with diabetes) were included. Measurements of anthropometry, plasma glucose, and plasma insulin at baseline and at follow-up were available for all of them. Indexes of insulin resistance (homeostasis model assessment of insulin resistance) and beta-cell function (insulinogenic index [DeltaI/G]: 30-min fasting insulin divided by 30-min glucose) were also analyzed in relation to the outcome.
Results: Subjects with IGT showed a deterioration in beta-cell function with time. Individuals with higher insulin resistance and/or low beta-cell function at baseline had poor outcome on follow-up. In relation to no abnormalities, the highest incidence of diabetes occurred when both abnormalities coexisted (54.9 vs. 33.7%, chi(2) = 7.53, P = 0.006). Individuals having abnormal insulin resistance (41.1%) or abnormal DeltaI/G (51.2%, chi(2) = 4.87, P = 0.027 vs. no abnormalities) had lower incidence. Normal beta-cell function with improved insulin sensitivity facilitated reversal to NGT, whereas deterioration in both resulted in diabetes. The beneficial changes were better with intervention than in the control group. Intervention groups had higher rates of NGT and lower rates of diabetes.
Conclusions: In the IDPP-1 subjects, beneficial outcomes occurred because of improved insulin action and sensitivity caused by the intervention strategies.
Figures
Figure 1
Median values of HOMA-IR (A, left panel) and ΔI/G (A, right panel) were calculated in relation to glycemic status (NGT, IGT [B], and diabetes [C]) at annual follow-up. The median values at the 1st-, 2nd-, and 3rd-year follow-up in comparison with the corresponding baseline values in these participants are shown in each category of glucose tolerance. A: 1st year n = 160, 2nd year n = 155, 3rd year n = 93. B: 1st year n = 201, 2nd year n = 152, 3rd year n = 150. C: 1st year n = 70, 2nd year n = 60, 3rd year n = 64. ▩, baseline; ▨, follow-up. *P < 0.05 vs. baseline values.
Similar articles
- Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).
Ramachandran A, Arun N, Shetty AS, Snehalatha C. Ramachandran A, et al. Diabetes Care. 2010 Oct;33(10):2164-8. doi: 10.2337/dc09-1150. Epub 2010 Jun 2. Diabetes Care. 2010. PMID: 20519663 Free PMC article. Clinical Trial. - Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V, Clementina M, Nair BM, Satyavani K. Viswanathan V, et al. J Assoc Physicians India. 2007 Dec;55:833-7. J Assoc Physicians India. 2007. PMID: 18405128 - The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). Ramachandran A, et al. Diabetologia. 2006 Feb;49(2):289-97. doi: 10.1007/s00125-005-0097-z. Epub 2006 Jan 4. Diabetologia. 2006. PMID: 16391903 Clinical Trial. - Prevention of type 2 diabetes: insulin resistance and beta-cell function.
Chiasson JL, Rabasa-Lhoret R. Chiasson JL, et al. Diabetes. 2004 Dec;53 Suppl 3:S34-8. doi: 10.2337/diabetes.53.suppl_3.s34. Diabetes. 2004. PMID: 15561919 Review. - Type 2 diabetes can be prevented with early pharmacological intervention.
DeFronzo RA, Abdul-Ghani M. DeFronzo RA, et al. Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S202-9. doi: 10.2337/dc11-s221. Diabetes Care. 2011. PMID: 21525456 Free PMC article. Review.
Cited by
- Low-calorie diets for people with isolated impaired fasting glucose.
Thirunavukkarasu S, Taylor R, Khunti K, Tapp RJ, Raben A, Zhu R, Kapoor N, Narayan KMV, Ali MK, Shaw JE. Thirunavukkarasu S, et al. Commun Med (Lond). 2024 Mar 1;4(1):35. doi: 10.1038/s43856-024-00466-2. Commun Med (Lond). 2024. PMID: 38429400 Free PMC article. - Predictive performance of triglyceride glucose index (TyG index) to identify glucose status conversion: a 5-year longitudinal cohort study in Chinese pre-diabetes people.
Chen X, Liu D, He W, Hu H, Wang W. Chen X, et al. J Transl Med. 2023 Sep 15;21(1):624. doi: 10.1186/s12967-023-04402-1. J Transl Med. 2023. PMID: 37715242 Free PMC article. - One-hour glucose is an earlier marker of dysglycemia than two-hour glucose.
Ha J, Chung ST, Bogardus C, Jagannathan R, Bergman M, Sherman AS. Ha J, et al. Diabetes Res Clin Pract. 2023 Sep;203:110839. doi: 10.1016/j.diabres.2023.110839. Epub 2023 Jul 21. Diabetes Res Clin Pract. 2023. PMID: 37482221 Free PMC article. - Risk of Death Associated With Reversion From Prediabetes to Normoglycemia and the Role of Modifiable Risk Factors.
Cao Z, Li W, Wen CP, Li S, Chen C, Jia Q, Li W, Zhang W, Tu H, Wu X. Cao Z, et al. JAMA Netw Open. 2023 Mar 1;6(3):e234989. doi: 10.1001/jamanetworkopen.2023.4989. JAMA Netw Open. 2023. PMID: 36976559 Free PMC article.
References
- Tumilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Loutheranta A, Rastas M, Salminen V, Uusitupa M: the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–1350 - PubMed
- Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537–544 - PubMed
- Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH: The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783–1789 - PubMed
- Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289–297 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous